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Steṕhane Chaignepain,k Juan D. Chavez,j Steṕhane Claverol,l Jürgen Cox,m Trisha Davis,oo
Gianluca Degliesposti,n Meng-Qiu Dong,o Nufar Edinger,p Cecilia Emanuelsson,q Marina Gay,r
Michael Götze,s Francisco Gomes-Neto,rr Fabio C. Gozzo,d Craig Gutierrez,t Caroline Haupt,u
Albert J. R. Heck,v Franz Herzog,w Lan Huang,t Michael R. Hoopmann,x Nir Kalisman,p
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ABSTRACT: The number of publications in the ﬁeld of
chemical cross-linking combined with mass spectrometry
(XL-MS) to derive constraints for protein three-dimensional
structure modeling and to probe protein−protein interactions
has increased during the last years. As the technique is now
becoming routine for in vitro and in vivo applications in
proteomics and structural biology there is a pressing need to
deﬁne protocols as well as data analysis and reporting formats.
Such consensus formats should become accepted in the ﬁeld
and be shown to lead to reproducible results. This ﬁrst,
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community-based harmonization study on XL-MS is based on the results of 32 groups participating worldwide. The aim of this
paper is to summarize the status quo of XL-MS and to compare and evaluate existing cross-linking strategies. Our study
therefore builds the framework for establishing best practice guidelines to conduct cross-linking experiments, perform data
analysis, and deﬁne reporting formats with the ultimate goal of assisting scientists to generate accurate and reproducible XL-MS
results.
Mass spectrometry (MS) is becoming increasinglypopular in the ﬁeld of structural biology, with great
implications for solving important biological questions. A
central technique in structural MS is chemical cross-linking
combined with MS (XL-MS). Since 2000, XL-MS and
computational modeling has advanced from investigating
three-dimensional structures of isolated proteins to decipher-
ing protein interaction networks.1−4 In the ﬁeld of integrated
structure analysis, XL-MS is often used in conjunction with
cryo-electron microscopy. As the chemical XL-MS approach
allows the capture of transient and weak interactions, it is now
becoming a routine technique for unraveling protein
interaction networks in their natural cellular environment.5
The knowledge obtained will signiﬁcantly advance our
understanding of the structure of functional complexes, the
topology of cellular networks and molecular details underlying
human pathologies.
Brieﬂy, the XL-MS approach relies on adding a chemical
reagent to a protein solution connecting two functional groups
of amino acid side chains. Cross-linker molecules consist of
two reactive groups that are separated via a spacer of deﬁned
length that allow to derive distance information on a protein or
a protein assembly. The cross-linked residues are usually
identiﬁed after enzymatic digestion of the covalently connected
protein(s) using LC/ESI-MS/MS (liquid chromatography/
electrospray ionization-tandem mass spectrometry) and the
resulting fragment ion spectra are computationally assigned to
the cross-linked peptides. The distance constraints imposed by
the chemical cross-linker on the protein’s tertiary structure
serve as a basis for subsequent computational modeling studies
to derive three-dimensional structural models (Scheme S1).
XL-MS can be applied to both proteins and protein complexes
and in the case of protein assemblies, the distance constraints
can be used to map the subunit topology. XL-MS is now
increasingly being used for deriving protein−protein inter-
action maps, both in vitro and in vivo, where interacting
proteins are covalently connected by the cross-linking
reaction.6−13
The wide acceptance of XL-MS by the proteomics and
structural biology communities reﬂects the increasing
importance of cross-linking data for elucidating protein
structures and protein−protein interactions. However, the
growth of the user base brings about challenges of its own:
Even a relatively superﬁcial glance at the literature shows a
huge diversity of cross-linkers, experimental workﬂows, and
computational pipelines. Moreover, the information provided
in scientiﬁc research articles that contain cross-linking data can
range from being quite detailed to very brief.
The heterogeneity of cross-linking protocols has mainly
emerged from the use of diﬀerent cross-linking chemistries and
diﬀerent designs of the corresponding cross-linker (e.g.,
noncleavable/cleavable, isotope-coded, or aﬃnity-tagged re-
agents). This, in turn, necessitated individual software
solutions speciﬁcally tailored to the analysis of data from the
experimental workﬂow. The most common database search
engines used in proteomics are not directly suitable for
interpreting mass spectra from cross-linked peptides. There-
fore, the majority of computational solutions have emerged
from laboratories that pioneered the application of XL-MS and
created tools speciﬁcally tailored for the analysis of cross-linked
peptides. Together with a current lack of formal or even
informal reporting standards, the present state of XL-MS may
confuse researchers that are interested in interpreting results
from XL-MS studies or in adopting the technology. Currently,
it is not clear which strategies are most suitable in general or
for a particular application, which makes it challenging to
objectively compare results obtained by diﬀerent groups.
Certainly, the challenges summarized above resemble those
of other disciplines. In particular, scientists active in “conven-
tional” proteomics research have tried to address the very same
issues over the past decade. Interlaboratory and software
comparison studies have been performed for diﬀerent
experimental strategies, including data-dependent acquisi-
tion,14 selected reaction monitoring,15−18 and most recently,
data-independent acquisition.19,20 In addition, regular com-
parative studies have been organized by the Association of
Biomolecular Resource Facilities (ABRF; https://abrf.org/
research-group/proteomics-research-group-prg and https://
abrf.org/research-group/proteomics-standards-research-group-
sprg). Together, these studies revealed limitations in
commonly used experimental and computational workﬂows,
but on the other hand also provided evidence for the
robustness of a particular technique when implemented in
diﬀerent laboratories according to standard operating
procedures.
Standardized ﬁle formats and reporting guidelines for
proteomics have been developed under the auspices of the
Proteomics Standards Initiative (PSI) of the Human Proteome
Organization (http://www.psidev.info).21 For example, as far
back as 2007, the ﬁrst recommendations for minimum
reporting standards in proteomics (Minimum Information
About a Proteomics Experiment, MIAPE) have been made,22
which have been followed by detailed guidelines of several
proteomics journals. PSI has also formalized open-ﬁle formats,
such as the mzML format for raw MS data23 and the
mzIdentML format for protein identiﬁcations.24 Such guide-
lines and open data formats have also led to an increase in the
deposition of proteomics data in open data repositories such as
the PRoteomics IDEntiﬁcations (PRIDE) archive, hosted by
the European Bioinformatics Institute (https://www.ebi.ac.uk/
pride/archive/),25 via the ProteomeXchange initiative
(https://www.proteomexchange.org).26
Initiatives for establishing standards and recommendations
of best practices within structural MS techniques, ion mobility-
MS (https://chemrxiv.org/articles/Recommendations_for_
R epo r t i n g_ I o n_Mob i l i t y_Ma s s _S p e c t r ome t r y _
Measurements/7072070), hydrogen/deuterium exchange
(manuscripts in preparation), and native MS are or have
recently emerged. Likewise, there is also a clear need for the
objective assessment of the methods and reporting standards
within the ﬁeld of XL-MS. For this purpose, several researchers
active in the ﬁeld of XL-MS decided to start a community-
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organized eﬀort with the goal of providing a ﬁrst overview of
common procedures in XL-MS to generate the basis for best
practices in the ﬁeld.
In this ﬁrst interlaboratory eﬀort, 32 groups worldwide
contributed, delivering a total of 58 cross-linking data sets. The
data reﬂect the great diversity of experimental and computa-
tional strategies employed, and to our knowledge, this is the
ﬁrst comprehensive study with the aim to harmonize the XL-
MS ﬁeld.
■ RESULTS
Study Design. We opted for a simple study design to
encourage participation from as many laboratories as possible,
including those with currently only little experience in XL-MS.
Invitations were sent out to research groups known to be active
in the ﬁeld from their published work and to attendants of the
Symposium of Structural Proteomics (SSP, http://www.
structuralproteomics.net/) meeting series. The guidelines
were kept quite simple, and each participant was provided
with a template spreadsheet to document their method and
report their results (Supporting Information). Bovine serum
albumin (BSA), a protein with a molecular weight of ∼66 kDa,
was selected as the study system. We requested that a certain
product from a widely available supplier should be used, and it
was speciﬁed to use a BSA concentration of 10 μM. Apart from
these restrictions, we left the contributing laboratories full
freedom to choose the experimental and computational
strategies of their choice. This included, among other
parameters, ﬂexibility regarding the choice of cross-linking
reagent and its concentration, buﬀer composition and pH,
reaction time and temperature, post-cross-linking sample
processing (digestion protocol, optional fractionation, and
enrichment of cross-linked products), conditions for LC/MS
analysis, and data analysis procedures (choice of software,
search parameters, validation of the results). In short, we
expected that participants would use the typical XL-MS
workﬂows established in their laboratories. The protocols used
by the individual participating laboratories were collected and
analyzed in the Sinz lab and are summarized in the Supporting
Information.
For data analysis, we provided the amino acid sequence of
mature BSA after cleavage of the signal peptide and propeptide
sequences (residues 25−607 of the UniProt entry P02769,
https://www.uniprot.org/uniprot/P02769) to ensure a uni-
form numbering scheme. Finally, we encouraged participants
to perform at least three replicates. As mentioned above, we
provided a template spreadsheet (Supporting Information)
that needed to be completed by the participants before a data
set would be considered for inclusion in the detailed
assessment of the results. An overview of the data sets
provided by diﬀerent laboratories is presented in Figure 1.
Protein System. BSA was selected as model protein for
this study as it is a globular and stable protein that is readily
available at low cost. Moreover, the three-dimensional
structure of BSA is well-known, and we selected the Protein
Data Bank entry 4F5S (https://www.rcsb.org/structure/4F5S)
for further interpretation of the results. As BSA possesses a
tendency toward forming dimers, this has to be considered
when interpreting the results (see also below).
Cross-Linking Reagents. As outlined above, the partic-
ipants of this study were free to choose the cross-linking
principle(s) on their own (Table S1, Supporting Information).
The majority of groups decided to use noncleavable,
homobifunctional, amine-reactive N-hydroxysuccinimide
(NHS) cross-linkers, i.e., bis(sulfosuccinimidyl)suberate
(BS3) or disuccinimidylsuberate (DSS) (Figure 2a). Both
cross-linkers only diﬀer by a sulfonic acid group that is
incorporated for increased water solubility and bridge a
distance of 11.4 Å, resulting in Cα−Cα distances of ∼27 Å
to be cross-linked.27 MS-cleavable cross-linkers, such as
disuccinimidylsulfoxide (DSSO) and disuccinimidyldibutyric
urea (DSBU), are increasingly being used as they allow a
targeted identiﬁcation of cross-linked product based on
characteristic reporter ions generated during MS/MS experi-
ments. MS-cleavability as a cross-linker feature is essential to
Figure 1. Overview of data sets provided by the participants of this
study: 32 groups participated in this study, yielding 58 separate cross-
linking workﬂows. Nine data sets had to be excluded due to missing
replicates and nonuniform conditions, resulting in a total of 49 data
sets that were further considered. Several workﬂows contain both in-
solution (47 samples) as well as in-gel digestion (10 samples) as
processing methods. The samples were considered only once during a
workﬂow analysis.
Figure 2. (a) Cross-linking reagents used in this study; noncleavable
cross-linkers are presented in red, MS-cleavable cross-linkers are
shown in blue, (b) reactivity, and (c) spacer length. The cross-linkers
used in this study are BS3 (bis(sulfosuccinimidyl)suberate, DSS
(disuccinimidylsuberate), DSP (dithiobis(succinimidylpropionate)),
DMTMM (4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methyl-morpholi-
nium chloride) with and without PDH (pimelic acid dihydrazide),
sulfo-SDA (sulfosuccinimidyl 4,4′-azipentanoate), CBSS (carboxy-
benzophenone sulfosuccinimide), DSSO (disuccinimidylsulfoxide),
DSBU (disuccinimidyldibutyric urea), BDP-NHP (N-hydroxyphtha-
lamide ester of biotin aspartate proline), CBDPS (cyanurbiotindi-
mercaptopropionyl succinimide), DC4 (1,4-bis(4-((2,5-dioxopyrroli-
din-1-yl)oxy)-4-oxobutyl)-1,4-diazabicyclo[2.2.2]octane-1,4-diium),
and MC4 (N,N′-bis(4-((2,5-dioxopyrrolidin-1-yl)oxy)-4-oxobutyl)-
morpholine).
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reduce the search space in conducting proteome-wide cross-
linking studies. The vast majority of cross-linkers used herein
target amine groups in proteins, i.e., lysine side chains, while
carboxylic acid groups, such as aspartic and glutamic acid
residues, are less frequently targeted (Figure 2b). The main
spacer lengths of the cross-linkers are determined by the three
most abundant cross-linkers used in this study, BS3 and DSS
(both 11.4 Å), DSBU (12.5 Å), and DSSO (10.1 Å) (Figure
2c).
Reaction Conditions. The reaction conditions were also
kept completely open to the participants, including cross-
linking reaction time, temperature, cross-linker excess, and pH
value of the cross-linking solution (Figure 3). Not surprisingly,
the pH value of the cross-linking reaction mixture was kept
around pH 7.4 to 7.5 in the majority of experiments in order to
resemble the physiological pH situation. A pH value of 8.0 that
was also used in some experiments has the advantage of
enhancing the reactivity of NHS esters with nucleophiles. The
temperature was kept to 20, 25, or 37 °C in the majority of
experiments, with lower temperature being applied only by a
few groups. For BSA, a temperature of 37 °C certainly does not
present a problem as it is a stable, globular protein, but for
delicate and unstable proteins one should take care to conduct
the cross-linking reaction at lower temperatures.
Instrument Platforms and Settings Used to Generate
XL-MS Data. The overwhelming majority of cross-linking data
were generated on orbitrap mass spectrometers (Figure 4).
Only two FTICR (SolariX and Velos FTICR) mass
spectrometers and one Q-TOF (Synapt G2 SI) instrument
were employed (Figure 4a). All groups used LC/ESI-MS/MS
analysis, applying for most experiments a resolving power of
60 000 or 120 000 (at m/z 200 or 400, as speciﬁed by the
manufacturer Thermo Fisher Scientiﬁc for orbitrap instru-
ments) (Figure 4b). For MS/MS experiments, a resolving
power of 15 000 or 30 000 was employed in most cases (Figure
4c). Details on enrichment of cross-linked species, considered
charge states, fragmentation methods, and MS3 resolution are
presented in the Supporting Information (Figure S1).
Figure 3. (a) Time, temperature, and cross-linker excess (XL-fold)
were set as variable parameters, presented as gray spheres. The
colored dots are projections of the 3D space onto 2D planes. (b) pH
values of the cross-linking reactions ranged between 7.0 and 8.2.
Figure 4. LC/MS/MS conditions applied. (a) MS instrumentation,
(b) MS resolving power, and (c) MS/MS resolving power. Resolving
power is deﬁned at m/z 200 for orbitrap instruments, while for ICR
instruments it is deﬁned at m/z 400. Please note that several research
groups generated data sets with diﬀerent instruments and settings.
Figure 5. (a) Software tools used in this study (a complete summary
is found in Table S2, Supporting Information). Red bars indicate that
the software is applicable only for noncleavable cross-linkers; blue
bars indicate that the software can be used for MS-cleavable cross-
linkers. (b) False discovery rates. (c) Mass tolerance MS. (d) Mass
tolerance MS/MS. For the Proteome Discoverer, data analysis was
performed using the XlinkX software node.
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Data Analysis and Validation Strategies. Strategies for
data analysis were highly diverse (Figure 5), reﬂecting the
variety in the XL-MS ﬁeld where nearly every group possesses
their own software tools tailored to ﬁt their speciﬁc needs. This
enormous variety is currently one of the most critical issues in
XL-MS, and we consider it as an important contribution of this
study to reﬂect this diversity. The false discovery rate (FDR)
plays an important role in this context, and from this study it
arose that most of the groups apply an FDR of 5% (Figure 5b).
Manual validation of the cross-links was performed for 66% of
the experiments, while in 34%, the data sets were not manually
checked. It is important to note that a mechanism to control
the FDR should exist in the software; although proper FDR
control is not trivial for small search spaces, manual validation
strategies might be especially beneﬁcial in such cases. Some
strategies provide additional layers of evidence that can be used
to better control the error rate. For example, isotope-coded,
noncleavable linkers provide two independent measures of
precursor and fragment masses and charge state information
for fragments independent of MS resolution; MS-cleavable
linkers provide three layers of information: intact precursors,
released fragments corresponding to intact peptide chains, and
fragments thereof. In the absence of such strategies, we
recommend that preferentially both, MS and MS/MS data,
should be recorded with high mass accuracy to rule out a false
assignment of cross-linked products. Clearly, some of these
eﬀects will only become apparent for samples of higher
complexity.
Identiﬁed Cross-Links. As we left it to the individual
participants whether to use in-solution or in-gel digestion as
the workup method before LC/MS/MS analysis, 47 data sets
were generated by in-solution digestion, while 10 samples
originated from in-gel digestion (Figure 1). As already
mentioned, BSA has a tendency to form dimers, which
somewhat complicates data analysis. In case only the BSA
monomer band is used for in-gel digestion and subsequent
generation of the cross-linking data set, one can deﬁnitely rule
out that cross-links are in fact representing intermolecular
interactions between two BSA molecules. On the other hand,
during the in-gel digestion procedure cross-links might get lost,
resulting in an overall lower number of cross-linked products.
Another aspect regards the reaction sites that were
considered during data analysis. Usually, NHS esters, such as
the mainly used cross-linkers BS3, DSS, DSBU, and DSSO, will
react with lysine, but they also exhibit a signiﬁcant reactivity
toward serine, threonine, and tyrosine. The pH used for
conducting the cross-linking reaction plays a signiﬁcant role as
amine reactivity is increased at higher pH values. Some
participants considered only Lys−Lys cross-links and neglected
the side-reactivity of NHS esters with hydroxy group-
containing amino acids. In this study, it became apparent
that Ser, Thr, and Tyr account for ∼30% of cross-linking sites
(Supporting Information, Figure S2). The reactivity of Ser,
Thr, and Tyr residues obviously depends on the reaction
conditions (cross-linker, pH value of the solution) as well as
local pKa value. It is not practicable to consider Lys, Ser, Thr,
and Tyr when analyzing very complex systems, such as
complete proteomes. Therefore, we suggest as a compromise
to consider for whole proteome samples only lysine as the
reactive sites of NHS ester cross-linkers, while for single
proteins or proteins assemblies, Lys, Ser, Thr, and Tyr might
be taken into account.
Figure 6 provides an overview about the reproducibility of
results obtained with the individual workﬂows of the
participants. For in-solution digestion workﬂows, the average
number of unique cross-links in BSA is 78, while for in-gel
digestion workﬂows using only the monomeric BSA band, the
average number is 44. The term “cross-link” refers to the
speciﬁc amino acid residues that are connected, irrespective of
diﬀerent peptide sequences due to missed cleavage sites or
modiﬁcations. The majority of participating laboratories came
up with similar numbers of unique cross-links, independently
of the cross-linking conditions used (Figure 6a). Three cross-
linking workﬂows however recorded a signiﬁcantly higher
number of cross-links (between 260 and 350). The reason
could be a false consideration of cross-links from BSA dimers
that in some preparations might have been a dominating
species due to inappropriate sample treatment. For in-gel
digestion workﬂows, up to 19 overlength cross-links were
reported in one data set, which could represent false-positives
due to partial unfolding as only the monomeric form of BSA
was considered in these samples (Figure 6b).
A more detailed inspection of the unique cross-links revealed
highly interesting insights: Data sets created from amine-
reactive cross-linkers (BS3, DSBU, DSS, DSSO, DC4, MC4,
CBDPS) using an in-solution digestion workﬂow yielded a
total of 1066 unique cross-links. A complete list of unique
cross-links, identiﬁed with cross-linkers reacting with nucleo-
philes (amine and hydroxy groups) and sorted by their
reproducibility, is provided as separate ﬁle in the Supporting
Information. In total, 601 of 1066 unique cross-links (56%)
were however identiﬁed in only one single data set (Figure 7).
This indicates an overall low reproducibility of cross-linking
results. The curve in Figure 7a shows that the number of
unique cross-links identiﬁed is inversely proportional to the
reproducibility of cross-links in the data sets (coeﬃcient of
proportionality ≃ −1). If the reproducibility across the data
sets is higher than 20%, the eﬀect of including more data sets,
diﬀerent reaction conditions, and analytical parameters
determines a linear increment of the number of cross-link
identiﬁcations. The intercept with the y-axis of the resulting
interpolated linear curves indicates the putative number of
cross-links in BSA to be between 73 and 88 (Figure 7b). This
Figure 6. Number of BSA cross-links identiﬁed. The numbers of
cross-links are plotted for (a) in-solution and (b) in-gel digestion
workﬂows. The diﬀerent cross-linkers are shown as symbols;
abbreviations of the cross-linkers are according to Figure 2. The
maximum distances are given for each cross-linker, indicating the
number of overlength cross-links. Every point is a sum of three
replicate measurements; replicates of the entire experiment are shown
in blue, and replicates of the LC/MS analyses are shown in red; the
average number and reproducibility of unique cross-links are shown in
yellow.
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value is very close to the average number of cross-links found
(78 cross-links per data set for in-solution digestion workﬂows,
Figure 6a). In Figure 7c, the dependence of the linear
correlation on the reproducibility of cross-links identiﬁed is
indicated. This indicates that a linear correlation only exists for
highly reproducible cross-links.
Cross-Links Identiﬁed from In-Gel Digested BSA
Monomer Band. We mapped cross-links in the monomer
band of BSA using in-gel digestion (in total 10 data sets) into
the published 3D structure of BSA (PDB entry 4F5S). For this,
a statistical analysis could be performed for homobifunctional,
amine-reactive linkers considered only for this type of cross-
linker. Only cross-links identiﬁed in at least two independent
experiments are presented (Figure S3). A total of 30 out of 230
cross-links exceeds the maximum length of 30 Å for the cross-
linkers employed in this study. These overlength cross-links
either originate from a false assignment or by applying
nonsuitable experimental conditions. Strikingly, 29 of these
overlength cross-links were identiﬁed in one single experiment
only. Cross-links that were identiﬁed in at least two
independent experiments show one overlength link, while
cross-links found in at least three independent experiments all
fall within the given distance limit of 30 Å (Figure S4). As
guideline for testing cross-linking workﬂows, we provide a list
of cross-links that were identiﬁed in at least two independent
experiments from in-gel digestion of the BSA monomer band
(Table S3, Supporting Information).
Monomer−Dimer Equilibrium of BSA. BSA exists in a
monomer−dimer equilibrium, which may give rise to
ambiguities in the identiﬁcation of intra- and intermolecular
cross-links. To address this issue, we performed additional
experiments with four concentrations of BSA (10, 5, 1, and 0.5
μM). Strikingly, the number of overlength cross-links was very
low (only 1 or 2). Moreover, the numbers of overlength cross-
links were similar for all four BSA concentrations used (Table
S4, Supporting Information). This clearly indicates that a BSA
concentration of 10 μM, as chosen for this study, is suitable for
conducting cross-linking MS experiments.
Comparison of Data Acquisition and Analysis
Strategies from One Participating Laboratory. Because
most of the data in this study have been generated in diﬀerent
laboratories, diﬀerences in instrumentation and in the software
used for data analysis make a direct comparison of selected
results diﬃcult. However, we used a subset of the data
generated in a single laboratory to study the eﬀect of the type
of mass spectrometer and of diﬀerent search settings on the
outcome for a relatively simple model system, such as BSA (see
Supporting Information).
■ DISCUSSION
This ﬁrst community-based cross-linking study reﬂects the
high diversity of XL-MS workﬂows that are currently employed
in diﬀerent laboratories worldwide. However, it also became
apparent that independent of the workﬂow used, the results
obtained are to some degree comparable. For beginners in the
ﬁeld, we suggest to use BSA as an initial study system and
compare the outcome to the results obtained herein. As a
guideline, the number of cross-links expected for BSA should
be ∼80 for an in-solution workﬂow, considering cross-links of
the monomer and the dimer. Not unexpectedly, our study did
not reveal the optimum experimental protocol or software to
be used in any and all projects. The applications of XL-MS are
just too diverse so that no single cross-linker, instrument, or
software tool is expected to be preferable for all scenarios,
ranging from single protein (as used in this work) to whole-cell
cross-linking. There are also clear interdependencies between
the type of cross-linker (cleavable, noncleavable) and the
software that can be applied to process such data as well as
between instrument type and software as not all fragmentation
methods or other MS platform-dependent features may be
supported.
As discussed above, XL-MS has become an essential part of
many structural proteomics studies but is also a key element in
integrative structural biology projects. In such interdisciplinary
work, XL data may only be a small “puzzle piece” that is
combined with other experimental data provided by methods
such as electron microscopy, X-ray crystallography, NMR
spectroscopy, small-angle X-ray scattering, together with
computational modeling. Details about how experiments
were carried out, how the data were processed, and how
error rates were assessed are often missing from the
publication, making it diﬃcult for reviewers and readers to
assess the reliability and credibility of the results. We therefore
recommend that appropriate consideration should be given to
the method section of all XL-MS publications by providing all
necessary experimental and computational details. Our
reporting template could serve as a starting point for the
“minimum information about a cross-linking experiment” that
should be included in research articles containing XL-MS data.
This template is included in the Supporting Information for all
XL-MS data reports. Suﬃcient information needs to be
provided, irrespective of the relative contribution of the
cross-linking experiments to a speciﬁc project. This will also
facilitate the cross-referencing of XL-MS data in integrative
structural biology projects, for example, in the dedicated PDB
prototype archive, PDB-Dev.28
Data deposition to a proteomics repository, such as PRIDE,
is encouraged, as the paucity of available data sets do not assist
the ﬁeld in validation, methods evaluation, and workﬂow
Figure 7. Comparison of unique cross-links. “Cross-link” denotes the
unique amino acid residues that are connected by homobifunctional,
amine-reactive cross-linkers. (a) Number of cross-links with respect to
their reproducibility among the data sets. (b) Linear extrapolation of
all (red) or a linear subset (blue) of cross-links resulted in a maximum
cross-linking number between 73 and 88. (c) Plot summarizes the
intercepts with the y-axis (red) and the correlation coeﬃcient × 100
(blue) of the respective linear extrapolations of part a. The linear
extrapolation was calculated as shown in part b by successively
removing the data points starting from the lowest reproducible value.
Analytical Chemistry Perspective
DOI: 10.1021/acs.analchem.9b00658
Anal. Chem. 2019, 91, 6953−6961
6959
quality. It should be noted that not all data sets assigned to the
cross-linking category in PRIDE originate from genuine XL-
MS experiments (in the sense that cross-linking sites were
identiﬁed) but also contain data from experiments that used
cross-linking for the stabilization of complexes. The low uptake
of data deposition may in part be due to the speciﬁc nature of
XL-MS data. For a “complete” submission to ProteomeX-
change, allowing a complete integration of search results and
assignment of a Digital Object Identiﬁer, the reported results
need to be compliant with a PSI format, such as mzIdentML.
Although the most recent version of mzIdentML (version 1.2)
includes support for some XL-MS strategies, such a
proteomics-centered format cannot easily consider all possible
workﬂows, and few dedicated cross-linking search engines oﬀer
mzIdentML-compliant export at this point. Nevertheless, even
a “partial” submission will make the raw MS data and results
available in a user-speciﬁed format for download and reuse by
interested researchers.
Additional studies that cover a wider range of sample types,
such as large multiprotein assemblies or even whole
proteomes, will be required to obtain a better understanding
of the beneﬁts and drawbacks of diﬀerent experimental
workﬂows. However, we believe that this ﬁrst community-
based study serves as the starting point for further initiatives in
this direction and encourages the adoption of consistent
reporting and data sharing guidelines in XL-MS. We would like
to invite interested parties to participate in the discussion to
expand the growing XL-MS community.
■ CONCLUSION AND GUIDELINES
Although XL-MS is becoming routine for in vitro and in vivo
applications in proteomics and structural biology, this
harmonization initiative unveiled a great variety in the cross-
links identiﬁed by participating groups, even for the single
protein BSA. This underlines the need for establishing
generally accepted XL-MS protocols as well as data analysis
and reporting formats. This interlaboratory study on XL-MS
represents the ﬁrst eﬀort of the community toward establishing
endorsed and transparent good practice guidelines for
performing and reporting XL-MS experiments. This study
also serves as test for all laboratories to evaluate the quality of
their XL-MS workﬂows and will aid in improving eventual
weaknesses. In summary, seven guidelines were deduced from
this study as framework for conducting XL-MS experiments as
detailed in Table 1.
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